SHIRE PLC SHPG Income Statement

Shire plc (SHPG)

Income statement / Quarterly

Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Dec'10	Sep'10	Jun'10	Mar'10	Dec'09	Sep'09	Jun'09	Mar'09	Sep'08	Jun'08
Revenues:
Total revenues
3,871,700	-	-	-	3,697,600	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Product sales
-	3,808,600	3,637,100	-	-	3,591,800	3,412,300	3,621,000	3,315,400	2,322,100	1,627,300	1,623,700	1,576,800	1,476,200	1,423,200	1,500,700	1,552,000	1,469,600	1,308,100	1,280,400	1,171,000	1,207,900	1,098,200	943,800	1,054,500	1,147,700	1,106,900	943,900	1,018,400	993,300	889,300	851,400	794,300	764,300	718,200	776,800	602,500	558,400	756,000	712,500	705,700
Royalties and other revenues
-	110,900	128,600	-	-	154,000	160,000	185,100	136,700	107,000	82,000	94,400	78,200	81,400	62,800	90,300	39,900	29,200	32,300	64,400	37,600	36,300	38,500	87,200	41,800	56,300	56,300	83,700	62,800	63,400	73,600	73,600	76,500	82,700	95,300	114,700	60,300	66,900	50,600	60,800	64,800
Other revenues
-	-	-	-	-	-	-	-	-	-	-	-	-	-	2,400	-	5,200	3,300	6,400	-	4,100	8,000	6,700	16,400	4,100	3,800	8,600	9,300	4,900	6,200	9,300	6,200	3,500	2,400	2,700	1,700	4,200	4,400	11,200	5,300	5,100
Total revenues
-	3,919,500	3,765,700	-	-	3,745,800	3,572,300	3,806,100	3,452,100	2,429,100	1,709,300	1,715,700	1,655,000	1,557,600	1,488,400	1,576,100	1,597,100	1,502,100	1,346,800	1,326,000	1,212,700	1,252,200	1,143,400	1,047,400	1,100,400	1,207,800	1,171,800	1,036,900	1,086,100	1,062,900	972,200	931,200	874,300	849,400	816,200	893,200	667,000	629,700	817,800	778,600	775,600
Costs and expenses:
Cost of sales
1,157,600	1,108,300	1,132,400	1,263,500	1,001,400	1,108,900	1,327,000	1,053,600	1,736,200	778,100	248,600	250,500	262,700	228,000	227,800	218,500	254,300	277,000	229,500	178,600	180,500	164,300	147,400	107,000	167,900	152,500	158,400	117,000	166,500	143,700	124,500	129,700	112,700	119,100	101,900	103,100	104,900	96,400	83,600	84,200	142,900
Research and development
407,200	427,600	405,200	438,800	402,800	542,400	379,300	416,800	511,100	294,800	217,100	353,200	241,200	775,900	193,700	241,500	228,600	236,900	360,500	230,100	226,200	256,500	220,600	269,400	224,700	238,600	220,300	208,200	201,500	176,900	177,900	185,600	197,900	147,000	131,000	147,500	147,800	158,700	185,900	120,200	136,400
Selling, general and administrative
836,800	907,700	804,800	883,200	859,700	899,100	888,900	989,400	875,600	675,300	474,900	397,600	442,300	496,000	506,600	332,600	522,900	496,200	430,300	301,300	396,300	410,000	391,700	499,600	437,400	511,000	500,000	380,400	452,100	440,300	402,900	419,600	392,400	354,400	359,900	368,400	320,600	334,700	318,900	327,300	437,700
Amortization of acquired intangible assets
433,700	457,600	484,000	487,900	482,400	434,100	364,000	470,900	354,900	213,000	134,600	-	132,700	131,300	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
In-process R&D ("IPR&D") charge
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	120,500	135,000
Gain on sale of product rights
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	9,100
Integration and acquisition costs
93,000	179,300	239,700	197,800	237,000	343,700	116,000	145,300	284,500	363,000	91,100	86,600	89,900	-212,400	75,700	3,000	37,100	112,100	6,600	-174,000	18,400	17,400	4,100	-1,600	2,700	7,100	5,300	-7,800	5,300	9,000	-6,400	1,600	5,800	0	600	700	6,200	2,300	1,400	7,500	0
Reorganization costs
254,800	8,800	5,300	23,400	5,400	13,600	5,500	5,700	101,400	11,000	3,300	38,300	31,100	13,300	15,200	57,500	28,200	45,800	49,400	41,000	12,000	17,700	17,500	0	0	0	0	6,300	5,000	7,500	5,500	11,000	9,700	8,600	5,000	5,600	2,000	2,900	2,200	0	0
Goodwill impairment charge
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	191,800	0	0	7,100	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-
(Gain)/loss on sale of Oncology and product rights
267,200	0	0	0	-300	-4,800	5,500	4,300	5,700	2,300	4,200	1,700	700	7,100	5,200	2,000	46,000	3,800	36,400	1,300	3,600	4,500	6,500	34,600	-5,700	-3,600	-7,200	-2,200	-300	-2,200	-1,300	12,400	0	4,100	0	-	6,300	-	-	4,000	-
Total operating expenses
2,915,900	3,089,300	3,071,400	3,294,600	2,989,000	3,346,600	3,075,200	3,077,400	3,858,000	2,332,900	1,165,400	1,359,200	1,199,200	1,425,000	1,013,800	1,094,900	1,025,100	1,164,200	1,039,900	727,700	829,800	861,400	781,900	872,800	827,000	905,600	876,800	706,300	830,700	779,600	705,700	735,100	718,500	625,000	598,400	625,300	575,200	595,000	592,000	655,700	842,900
Operating income from continuing operations
955,800	830,200	694,300	850,300	708,600	399,200	497,100	728,700	-405,900	96,200	543,900	356,500	455,800	132,600	474,600	481,200	572,000	337,900	306,900	598,300	382,900	390,800	361,500	174,600	273,400	302,200	295,000	330,600	255,400	283,300	266,500	196,100	155,800	224,400	217,800	267,900	91,800	34,700	225,800	122,900	-67,300
Interest income
1,300	900	2,600	4,000	1,500	1,100	3,100	6,500	9,300	1,600	1,000	800	800	600	2,000	1,900	3,600	18,700	500	500	400	500	700	700	900	600	800	400	300	600	600	500	1,000	500	400	500	200	600	600	3,800	6,500
Interest expense
125,200	125,900	127,000	153,500	141,800	141,300	142,300	150,800	186,900	87,200	44,700	10,000	10,700	11,300	9,600	5,100	6,800	11,100	7,800	10,600	9,200	9,100	9,200	9,200	9,200	9,600	10,200	10,300	9,700	9,900	9,200	9,500	8,300	8,300	9,000	9,300	9,400	10,100	11,000	92,900	16,800
Other (expense)/income, net
-96,100	29,000	23,200	600	-200	2,500	4,500	-9,400	-13,700	6,000	-8,500	-8,200	9,600	-2,000	4,300	-5,900	6,800	3,300	4,700	-2,300	700	-1,300	-1,000	-5,800	3,500	-1,800	1,900	2,600	15,600	0	300	-1,100	800	-2,600	10,800	-1,300	7,000	4,700	50,300	-52,000	700
Total other expense, net
-220,000	-96,000	-101,200	-148,900	-140,500	-137,700	-134,700	-153,700	-191,300	-79,600	-52,200	-17,400	-300	-12,700	-3,300	1,626,300	3,600	10,900	-2,600	-	-8,100	-9,900	-9,500	-	-4,800	-10,800	-7,500	-7,300	6,200	-9,300	-8,300	-10,100	-6,500	-10,400	2,200	-10,100	-2,200	-4,800	39,900	-141,100	-9,600
Income from continuing operations before income taxes and equity in earnings of equity method investees
735,800	734,200	593,100	701,400	568,100	261,500	362,400	575,000	-597,200	16,600	491,700	339,100	455,500	119,900	471,300	2,107,500	575,600	348,800	304,300	585,900	374,800	380,900	352,000	160,300	268,600	291,400	287,500	323,300	261,600	274,000	258,200	186,000	149,300	214,000	220,000	257,800	89,600	29,900	265,700	-18,200	-76,900
Income taxes
203,300	124,400	43,300	-2,402,200	13,500	24,300	6,800	92,300	-229,600	-70,900	82,100	55,100	-22,300	-44,100	57,400	120,800	61,200	-176,500	50,600	42,600	73,400	90,500	71,400	58,500	41,600	53,000	50,000	49,600	69,500	69,700	48,100	21,900	52,700	54,500	53,600	81,800	30,600	-23,400	49,500	18,700	200
Equity in earnings/(losses) of equity method investees, net of taxes
4,700	5,700	800	2,400	-3,400	4,300	-800	-6,800	-900	-900	-100	-600	-700	100	-1,000	-1,100	1,400	3,000	-600	3,300	-300	500	400	500	200	-600	900	-700	800	1,200	1,200	1,200	-300	1,000	-500	-1,700	600	500	-100	1,600	-1,900
Income from continuing operations, net of taxes
537,200	615,500	550,600	3,106,000	551,200	241,500	354,800	475,900	-368,500	86,600	409,500	283,400	477,100	164,100	412,900	1,985,600	515,800	528,300	253,100	546,600	301,100	290,900	281,000	-	-	-	-	-	-	-	-	-	-	-	-	174,300	59,600	53,800	216,100	-35,300	-79,000
(Loss)/gain from discontinued operations, net of taxes
0	0	0	-600	-400	-1,200	20,200	-18,600	-18,300	-248,700	9,500	-2,800	-24,300	-4,500	-2,500	186,700	-36,100	-5,200	-22,700	-482,600	-22,900	-32,800	-216,200	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-9,800	-2,600	-900	0
Add: Net loss attributable to the noncontrolling interest in subsidiaries
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-100	-100	-1,300	0
Net income
537,200	615,500	550,600	3,105,400	550,800	240,300	375,000	457,300	-386,800	-162,100	419,000	280,600	452,800	159,600	410,400	2,172,300	479,700	523,100	230,400	64,000	278,200	258,100	64,800	42,000	227,200	237,800	238,400	255,300	192,900	205,500	211,300	-	96,300	160,500	-	174,300	59,600	44,100	213,600	-34,900	-79,000
Earnings per Ordinary Share basic
Earnings from continuing operations (in usd per share)
0.59	0.67	0.61	3.42	0.61	0.27	0.39	0.38	-0.41	0.12	0.69	0.48	0.81	0.28	0.70	3.38	0.87	0.90	0.43	0.98	0.54	0.52	0.51	-	-	-	-	-	-	-	-	-	-	-	-	0.32	0.11	0.10	0.40	-0.06	-0.14
Earnings from discontinued operations (in usd per share)
0.00	0.00	0.00	0.00	0.00	0.00	0.02	0.01	-0.02	-0.36	0.02	-0.01	-0.04	-0.01	0.00	0.31	-0.06	-0.00	-0.03	-0.87	-0.04	-0.06	-0.39	-	-	-	-	-	-	-	-	-	-	-	-	0.00	0.00	-0.01	-0.00	-0.00	0.00
Earnings per Ordinary Share - basic (in usd per share)
0.59	0.67	0.61	3.42	0.61	0.27	0.41	0.39	-0.43	-0.24	0.71	0.47	0.77	0.27	0.70	3.70	0.81	0.89	0.39	0.11	0.50	0.46	0.11	0.07	0.40	0.42	0.43	0.46	0.35	0.37	0.38	0.30	0.17	0.29	0.30	0.32	0.11	0.08	0.39	-0.06	-0.14
Earnings per Ordinary Share diluted
Earnings from continuing operations (in usd per share)
0.58	0.67	0.60	3.41	0.60	0.26	0.39	0.37	-0.41	0.12	0.69	0.49	0.80	0.28	0.69	3.35	0.87	0.89	0.43	0.92	0.52	0.50	0.49	-	-	-	-	-	-	-	-	-	-	-	-	0.32	0.10	0.09	0.38	-0.06	-0.14
Earnings from discontinued operations (in usd per share)
0.00	0.00	0.00	0.00	0.00	0.00	0.02	0.01	-0.02	-0.36	0.02	-0.01	-0.04	-0.01	0.00	0.31	-0.06	-0.00	-0.03	-0.81	-0.03	-0.05	-0.36	-	-	-	-	-	-	-	-	-	-	-	-	0.00	-0.00	-0.01	-0.00	-0.00	0.00
Earnings per Ordinary Share - diluted (in usd per share)
0.58	0.67	0.60	3.41	0.60	0.26	0.41	0.38	-0.43	-0.24	0.71	0.48	0.76	0.27	0.69	3.67	0.80	0.88	0.39	0.11	0.48	0.45	0.12	0.08	0.39	0.41	0.41	0.44	0.33	0.35	0.37	0.29	0.17	0.28	0.29	0.32	0.10	0.08	0.38	-0.06	-0.14
Cash dividends declared per ordinary share (in USD per share)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.00	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash dividends paid per ordinary share (in USD per share)
-	-	-	-	-	-	-	-	-	-	-	-	0.00	0.19	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Weighted average number of shares:
Basic (in shares)
914,000	912,600	909,500	908,300	907,200	906,400	904,100	905,700	900,200	682,800	591,700	591,100	590,900	590,500	589,100	588,500	587,600	586,400	584,300	558,500	548,400	549,600	551,500	555,200	555,900	557,000	553,500	551,300	551,300	552,300	549,500	547,300	547,000	546,600	543,900	543,100	540,600	539,900	539,200	540,300	542,500
Diluted (in shares)
921,100	917,500	912,100	911,900	911,600	912,700	911,800	928,500	900,200	682,800	593,300	593,100	593,400	593,200	592,700	593,500	592,600	590,300	588,800	600,600	585,700	586,000	588,900	590,400	593,100	594,900	595,600	599,100	593,800	595,100	593,600	628,400	556,700	590,000	586,100	523,100	548,300	543,400	577,200	540,300	542,500
Income from continuing operations, net of taxes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	174,300	59,600	53,900	216,200	-34,000	-79,000
Loss from discontinued operations, net of taxes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-9,800	-2,600	-900	0
Numerator for basic earnings per share
537,200	615,500	550,600	3,105,400	550,800	240,300	375,000	-	-386,800	-162,100	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	192,900	205,500	211,300	-	96,300	160,500	-	174,300	59,600	44,100	213,600	-34,900	-79,000
Amortization Cost Of Product Sales
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	400	400	-	-	-
Amortization and impairment charges recorded to selling general and administrative
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	34,800	34,300	-	-	-